Regencell Bioscience HoldingRGC
13F holders, Q1 2024 (March 31)3holders
$4.50avg. 13F price*
At the end of Q1 2024, 3 institutions reported holding Regencell Bioscience Holding (RGC) in their 13F filings. The largest holders were UBS Group AG ($6K), BlackRock Inc. ($1K) and Qube Research & Technologies Ltd ($64).
- Company
- Regencell Bioscience Holding
- CUSIP
- G7487R100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 3 holders
| UBS Group AG | 0.00% | Reduce -91.3% | 1,400 | $6K |
| BlackRock Inc. | 0.00% | No change | 238 | $1K |
| Qube Research & Technologies Ltd | 0.00% | No change | 13 | $64 |
"% of holder's portfolio" is RGC's weight in each manager's 13F, not the share of Regencell Bioscience Holding the manager owns.